-
JAMA Neurology publishes landmark study showing neuropacs™ AI technology significantly enhances the diagnostic accuracy of Parkinson’s disease and atypical parkinsonism
NIH-funded clinical trial accelerates the launch of innovative software for Parkinson’s Disease diagnostic. GAINESVILLE, FL – neuropacsTM Corp., a leading innovator in AI-driven neurological diagnostics, announces the results of a prospective multicenter study that evaluated neuropacs™ AI technology for diagnosing Parkinson’s disease and atypical parkinsonism. The study was published in JAMA Neurology (doi: 10.1001/jamaneurol.2025.0112) and…
-
The journey of a typical patient suffering from Parkinson’s Disease
-
Automated Imaging Diagnostics Awarded Phase II Grant for Clinical Performance Testing of neuropacs™ in Parkinsonism Diagnosis
FOR IMMEDIATE RELEASE GAINESVILLE, FL. Automated Imaging Diagnostics (AID), a wholly-owned subsidiary of neuropacs Corp., a pioneering force in neurological diagnostic technologies, is thrilled to announce the awarding of a Small Business Technology Transfer (STTR) Phase II NIH NIA/NINDS grant to conduct a comprehensive pre-market field evaluation of its cutting-edge product, neuropacs™, specifically tailored for…
-
Revolutionary Alzheimer’s Diagnostic Technology Option Agreement Secured by neuropacs in Collaboration with UF
GAINESVILLE, FL – neuropacsTM, a leading innovator in medical diagnostics, is excited to announce the acquisition of an exclusive option agreement for a groundbreaking diagnostic technology for Alzheimer’s disease developed at the University of Florida. This innovative technology, spearheaded by neuropacsTM‘s Co-Founder and Chief Scientific Officer, David Vaillancourt, has the potential to revolutionize early detection…
-
Phase I STTR grant from NIH/NINDS to Enhance neuropacs Technology for Parkinsonism Classification
FOR IMMEDIATE RELEASE GAINESVILLE, FL. Automated Imaging Diagnostics, a leading innovator in medical technology, is proud to announce that its flagship product, neuropacsTM, has been awarded a Phase I Small Business Technology Transfer (STTR) grant from the National Institutes of Health, an NIH institute. This grant will drive forward the evolution of neuropacsTM and the…
-
Neuropacs Appoints Dr. David R. Nelson to its Board of Advisors
Company secures a visionary health affairs leader for the launch of their innovative Parkinson’s diagnosis software. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that David R. Nelson, MD has accepted to serve on neuropacs’ Board of Advisors, effective immediately. Dr. Nelson is the former Senior Vice President for Health…
Read more about Neuropacs Appoints Dr. David R. Nelson to its Board of Advisors
-
Neuropacs Welcomes Dr. Andrew Siderowf as a Member of its Board of Clinical Advisors
Company interfaces with a world-renowned clinician for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Andrew Siderowf, MD, MS , has accepted to serve on neuropacs’ Board of Clinical Advisors. Dr. Siderowf is the Hurtig-Stern Professor of…
Read more about Neuropacs Welcomes Dr. Andrew Siderowf as a Member of its Board of Clinical Advisors
-
Neuropacs Enrolls Dr. Charles H. Adler on its Board of Clinical Advisors
Company retains an influential clinician for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Charles H. Adler, MD, PhD, has accepted to serve on neuropacs’ Board of Clinical Advisors. “Dr. Adler brings much clinical expertise and insight…
Read more about Neuropacs Enrolls Dr. Charles H. Adler on its Board of Clinical Advisors
-
Neuropacs Retains Dr. Jackson Streeter as a Member of its Board of Directors
Company secures a seasoned entrepreneur for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Dr. Jackson Streeter has accepted to serve on neuropacs’ Board of Directors. Dr. Streeter comes to neuropacs as the current Director of UF-Innovate/Ventures…
Read more about Neuropacs Retains Dr. Jackson Streeter as a Member of its Board of Directors
-
Neuropacs Enrolls Dr. David K. Simon on its Board of Clinical Advisors
Company retains an influential clinician for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that David K. Simon, MD, PhD, has accepted to serve on neuropacs’ Board of Clinical Advisors. “Dr. Simon brings cutting-edge clinical expertise to neuropacs”…
Read more about Neuropacs Enrolls Dr. David K. Simon on its Board of Clinical Advisors
-
Neuropacs Welcomes Dr. Jill Ostrem as the latest Member of its Board of Clinical Advisors
Company brings a world-acclaimed clinician and researcher for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Dr. Ostrem has accepted to serve on neuropacs’ Board of Clinical Advisors. Dr. Jill Ostrem is a movement disorders neurologist and…
-
Neuropacs Retains Mr. Rick Staab as a Member of their Board of Directors
Company retains entrepreneur and philanthropist to contribute to the launch of neuropacs’ innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Mr. Rick Staab has accepted to serve on neuropacs’ Board of Directors. Mr. Rick Staab is the former President and CEO of…
Read more about Neuropacs Retains Mr. Rick Staab as a Member of their Board of Directors